Non-specific physical interaction with pathogens and nasal microbiota

The target "Non-specific physical interaction with pathogens and nasal microbiota" refers to a therapeutic approach that relies on mechanical or physical barriers rather than specific molecular binding to a host receptor or enzyme (1). This mechanism is primarily utilized by nasal sprays and medical devices designed to prevent or treat respiratory infections by creating a protective layer over the nasal mucosa (2). These agents, such as iota-carrageenan or cellulose derivatives, physically trap inhaled pathogens like viruses and bacteria, thereby preventing them from attaching to and infecting the nasal epithelial cells (3). Beyond pathogen sequestration, these interactions can also modulate the local nasal microbiota by altering the physical environment, though this is typically a non-specific effect (4). Because the action is physical, these therapies often exhibit a broad-spectrum efficacy against various respiratory viruses regardless of their specific surface proteins (1). This classification is used when a drug's primary benefit is derived from these non-specific physical properties rather than a defined pharmacological pathway (2).

Other names

Physical barrierNasal mucosal barrierNon-specific viral sequestrationMucoadhesion-mediated pathogen entrapment

Physical sequestration and entrapment of pathogens to prevent cellular entry.